Of note, pretreatment of tumor cells resulted in an equal phagocytosis induction as when adding the antibody directly to the macrophage-tumor cell mix, which is explained by CD47-Sirpα disruption on GBM, whereas pretreatment of macrophages alone was not correlated to higher tumor-cell phagocytosis. Here, CD47 is linked to glioblastoma.